Search Results

Comorbid LUTS and erectile dysfunction: optimizing their management

Author: Kaminetsky, Jed C.

Source: Current Medical Research and Opinion, Volume 22, Number 12, December 2006 , pp. 2497-2506(10)

Publisher: Informa Healthcare

Noninvasive Management of Lower Urinary Tract Symptoms and Sexual Dysfunction Associated With Benign Prostatic Hyperplasia in the Primary Care Setting

Author: Kuritzky, Louis

Source: Comprehensive Therapy, Volume 31, Number 3, September 2005 , pp. 194-208(15)

Publisher: Humana Press

Inhibiting Biosynthesis and/or Metabolism of Progestins in the Ventral Tegmental Area Attenuates Lordosis of Rats in Behavioural Oestrus

Authors: Petralia, S. M.; Jahagirdar, V.; Frye, C. A.

Source: Journal of Neuroendocrinology, Volume 17, Number 9, September 2005 , pp. 545-552(8)

Publisher: Blackwell Publishing

Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5-Reductase Inhibitors

Authors: Bratoeff Eugene; Cabeza Marisa; Ramirez Elena; Heuze Yvonne; Flores Eugenio

Source: Current Medicinal Chemistry, Volume 12, Number 8, April 2005 , pp. 927-943(17)

Publisher: Bentham Science Publishers

Evaluation of Cell Permeation of a Potent 5-Reductase Inhibitor Using MALDI-TOF MS

Authors: Sonal Mathur; Franck Picard; Ulrich Dossou; Catherine Barassin; Stefanie B. Seidel; Min-Jung Kang; Rolf W. Hartmann

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 19, Number 5, October, 2004 , pp. 425-429(5)

Publisher: Informa Healthcare

Agents in development for prostate cancer prevention

Author: William G Nelson

Source: Expert Opinion on Investigational Drugs, Volume 13, Number 12, 1 December 2004 , pp. 1541-1554(14)

Publisher: Informa Healthcare

Management of Benign Prostatic Hyperplasia: Defining the Role of Tamsulosin

Authors: Katherine F. Croom; Antona J. Wagstaff

Source: Disease Management & Health Outcomes, Volume 12, Number 5, 2004 , pp. 337-350(14)

Publisher: Adis International

Preventing diseases of the prostate in the elderly using hormones and nutriceuticals

Authors: F Comhaire; A Mahmoud

Source: The Aging Male, Volume 7, Number 2, June 2004 , pp. 155-169(15)

Publisher: Informa Healthcare

The Management of Prostatic Obstruction: How to Determine the Best Options?

Authors: Roehrborn C.G.; McNicholas T.

Source: European Urology Supplements, Volume 2, Number 8, November 2003 , pp. 13-19(7)

Publisher: Elsevier

LUTS and Sexual Dysfunction: Implications for Management of BPH

Author: van Moorselaar J.

Source: European Urology Supplements, Volume 2, Number 10, December 2003 , pp. 13-20(8)

Publisher: Elsevier

Dutasteride:

Authors: Evans H.C.; Goa K.L.

Source: Drugs & Aging, Volume 20, Number 12, 2003 , pp. 905-916(12)

Publisher: Adis International

Drug Treatments for Lower Urinary Tract Symptoms Secondary to Bladder Outflow Obstruction: Focus on Quality of Life

Authors: MacDonald D.; McNicholas T.A.

Source: Drugs, Volume 63, Number 18, 2003 , pp. 1947-1962(16)

Publisher: Adis International

The novel dual 5-reductase inhibitor dutasteride is well tolerated with the concomitant use of commonly prescribed cardiovascular medications and PDE-5 inhibitors

Authors: McNicholas T.; Tamella T.; Te A.; Harkaway R.

Source: European Urology Supplements, Volume 2, Number 1, February 2003 , pp. 74-74(1)

Publisher: Elsevier

Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat

Authors: Bowman C.J.; Barlow N.J.; Turner K.J.; Wallace D.G.; Foster P.M.D.

Source: Toxicological Sciences, Volume 74, Number 2, August 2003 , pp. 393-406(14)

Publisher: Oxford University Press

Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 4-reductase mRNA isozymes in rat ventral prostate in different androgen status

Authors: Torres J.M.; Gómez-Capilla J.A.; Ruiz E.; Ortega E.

Source: Molecular and Cellular Biochemistry, Volume 250, Numbers 1-2, August 2003 , pp. 125-130(6)

Publisher: Springer

Steroidal nitrone inhibitors of 5-reductase

Authors: Robinson A.J.; DeLucca I.; Drummond S.; Boswell G.A.

Source: Tetrahedron Letters, Volume 44, Number 25, 16 June 2003 , pp. 4801-4804(4)

Publisher: Elsevier

Effects of novel 17-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo

Authors: Haidar S.; Ehmer P.B.; Barassin S.; Batzl-Hartmann C.; Hartmann R.W.

Source: The Journal of Steroid Biochemistry and Molecular Biology, Volume 84, Number 5, April 2003 , pp. 555-562(8)

Publisher: Elsevier

Steroid 5-Reductase Inhibitors

Authors: Flores E.; Bratoeff E.; Cabeza M.; Ramirez E.; Quiroz A.; Heuze I.

Source: Mini Reviews in Medicinal Chemistry, Volume 3, Number 3, May 2003 , pp. 225-237(13)

Publisher: Bentham Science Publishers

The extract of Thujae occidentalis semen inhibited 5-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse

Authors: Park W.-s.; Lee C.-h.; Lee B.-g.; Chang I.-s.

Source: Journal of Dermatological Science, Volume 31, Number 2, April 2003 , pp. 91-98(8)

Publisher: Elsevier

Effect of a novel steroid (PM-9) on the inhibition of 5-reductase present in Penicillium crustosum broths

Authors: Flores E.; Cabeza M.; Quiroz A.; Bratoeff E.; Garca G.; Ramrez E.

Source: Steroids, Volume 68, Number 3, March 2003 , pp. 271-275(5)

Publisher: Elsevier